Nebraska Clinical Trials

Recruiting studies in Nebraska

• Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
  NCT05633654PHASE3Gilead SciencesTriple Negative Breast CancerHastings, NE
• A Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental Vitiligo
  NCT07431177PHASE2Novartis PharmaceuticalsNon-segmental VitiligoOmaha, NE
• A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Other Anticancer Drugs in Adult Participants With Ovarian Cancer
  NCT07278336PHASE1AbbVieOvarian CancerOmaha, NE
• A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis
  NCT05828069PHASE2National Cancer Institute (NCI)Recurrent Langerhans Cell HistiocytosisOmaha, NE
• Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
  NCT07116967PHASE3Bristol-Myers SquibbPlaque PsoriasisOmaha, NE
• Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer
  NCT07195734PHASE2National Cancer Institute (NCI)Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Omaha, NE
• Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
  NCT04613596PHASE2, PHASE3Mirati Therapeutics Inc.Advanced Non-Small Cell Lung CancerGrand Island, NE
• ALTO-100 in Bipolar Disorder With Depression (BD-D)
  NCT06656416PHASE2Alto NeuroscienceBipolar Disorder I or II With a Major Depressive EpisodeLincoln, NE
• MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma
  NCT05655312PHASE1, PHASE2Perspective TherapeuticsRecurrent Melanoma (Skin)Omaha, NE
• A Study to Assess the Efficacy and Safety of GIA632 Across a Range of Doses in Participants With Moderate to Severe Cutaneous Lichen Planus
  NCT07775924PHASE2Novartis PharmaceuticalsCutaneous Lichen PlanusOmaha, NE
• Abbott Vascular Medical Device Registry
  NCT04573660Abbott Medical DevicesAcute Myocardial InfarctionLincoln, NE
• Lisaftoclax (APG-2575) Combined With Azacytidine (AZA) in the Treatment of Patients With Higher-risk Myelodysplastic Syndrome (GLORA-4).
  NCT06641414PHASE3Ascentage Pharma Group Inc.Higher-risk Myelodysplastic SyndromeLincoln, NE

See all 653 recruiting trials →

Popular conditions in Nebraska

• Breast Cancer
• Prostate Cancer
• Lung Cancer
• Colorectal Cancer
• Obesity
• Type 2 Diabetes
• Depression
• Alzheimer Disease
• Heart Failure
• Multiple Sclerosis
• Rheumatoid Arthritis
• Asthma
• Non-small Cell Lung Cancer
• Small Cell Lung Cancer
• Pancreatic Cancer
• Pancreatic Ductal Adenocarcinoma

Frequently asked questions

How do I find clinical trials in Nebraska?

Corterve aggregates actively recruiting clinical trials with sites in Nebraska from the public ClinicalTrials.gov registry. Browse the studies on this page or take an assessment to find trials you may qualify for.

Are clinical trials in Nebraska free to join?

Costs, travel support, and any payment for taking part vary by study. Ask the study team what is covered before you decide to join.

What kinds of clinical trials are available in Nebraska?

Nebraska research sites run studies across many areas including oncology, neurology, cardiology, and metabolic health. This page is general information and not medical advice; confirm any specific trial with your healthcare provider.